CAMBRIDGE & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its ...
Only a few years ago the benefits of lateral flow diagnostic tests weren’t widely understood outside of scientific circles. The reason most people came into contact with the technology was through the ...
In what U.S. FDA commissioner Stephen Hahn billed as “a major milestone” in testing for the COVID-19 pandemic, the FDA has granted an emergency use authorization (EUA) to Ellume Ltd., of East Brisbane ...
Jack has a degree in Medical Genetics from the University of Leicester.View full profile Jack has a degree in Medical Genetics from the University of Leicester. As the coronavirus pandemic continues ...
Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...
(Reuters) -Britain's Avacta Group is halting sales of its COVID-19 rapid antigen lateral flow test to replace antibodies in the device and boost its ability to detect the Omicron variant, the biotech ...
The UK government recently asked all secondary schools to provide on-site COVID-19 testing for pupils, and advised secondary, college and university students to continue twice weekly testing, in an ...
CAMBRIDGE, England & WETHERBY, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer ® and pre|CISION ™ ...
In a recent review published in Nature Reviews Bioengineering, researchers assessed the changing landscape of lateral flow tests (LFTs), and the development of next-generation LFTs based on lessons ...
The performance of lateral flow (antigen) tests commonly used to detect COVID-19 infection in children falls short of the minimum criteria set by the World Health Organization (WHO) and US and UK ...
A Covid-19 lateral flow test showing a negative result. Routine testing to identify those infected followed by efficient contact tracing, and supported isolation is still the most effective public ...
Bond Digital Health Ltd. landed £1 million (US$1.3 million) from investors to expand development of its Transform data management system for lateral flow diagnostic tests. The technology connects to ...